Although late onset ACTH deficiency is well known in CH patients with PROP1 mutations [18]–[20] and LHX3 [21], our study showed, for the first time, that a gradual loss of ACTH should be a point of concern among CH patients with LHX4 mutations. The gene discussed is LHX3; the disease is cyclic hematopoiesis.